BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 21715692)

  • 1. 4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells.
    Kim YH; Choi BK; Shin SM; Kim CH; Oh HS; Park SH; Lee DG; Lee MJ; Kim KH; Vinay DS; Kwon BS
    J Immunol; 2011 Aug; 187(3):1120-8. PubMed ID: 21715692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma.
    Choi BK; Kim YH; Kim CH; Kim MS; Kim KH; Oh HS; Lee MJ; Lee DK; Vinay DS; Kwon BS
    J Immunol; 2010 Aug; 185(3):1404-11. PubMed ID: 20610645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo.
    Choi BK; Kim YH; Choi JH; Kim CH; Kim KS; Sung YC; Lee YM; Moffett JR; Kwon BS
    Cytokine; 2011 Sep; 55(3):420-8. PubMed ID: 21700476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
    Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
    J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NF-κB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis.
    Chen G; Hardy K; Pagler E; Ma L; Lee S; Gerondakis S; Daley S; Shannon MF
    J Immunol; 2011 Nov; 187(9):4483-91. PubMed ID: 21940679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes.
    Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A
    J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE.
    Gültner S; Kuhlmann T; Hesse A; Weber JP; Riemer C; Baier M; Hutloff A
    Eur J Immunol; 2010 Dec; 40(12):3403-12. PubMed ID: 21108463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFR2 on non-haematopoietic cells is required for Foxp3+ Treg-cell function and disease suppression in EAE.
    Tsakiri N; Papadopoulos D; Denis MC; Mitsikostas DD; Kollias G
    Eur J Immunol; 2012 Feb; 42(2):403-12. PubMed ID: 22105853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK inhibitors suppress Th17 and promote iTreg differentiation, and ameliorate experimental autoimmune encephalomyelitis in mice.
    Yoshida H; Kotani H; Kondo T; Tani I; Wei X; Tsuruta S; Kimura A; Asakawa M; Ito M; Nagai S; Yoshimura A
    Biochem Biophys Res Commun; 2013 Jun; 435(3):378-84. PubMed ID: 23665028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression.
    Zhang P; Gao F; Wang Q; Wang X; Zhu F; Ma C; Sun W; Zhang L
    Scand J Immunol; 2007 Oct; 66(4):435-40. PubMed ID: 17850588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology.
    Stange J; Hepworth MR; Rausch S; Zajic L; Kühl AA; Uyttenhove C; Renauld JC; Hartmann S; Lucius R
    J Immunol; 2012 Mar; 188(5):2410-8. PubMed ID: 22266282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of all-trans-retinal-induced regulatory T cells ameliorates experimental autoimmune arthritis in an interferon-gamma knockout model.
    Jeon EJ; Yoon BY; Lim JY; Oh HJ; Park HS; Park MJ; Lim MA; Park MK; Kim KW; Cho ML; Cho SG
    Autoimmunity; 2012 Sep; 45(6):460-9. PubMed ID: 22559266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic proof for the transient nature of the Th17 phenotype.
    Kurschus FC; Croxford AL; Heinen AP; Wörtge S; Ielo D; Waisman A
    Eur J Immunol; 2010 Dec; 40(12):3336-46. PubMed ID: 21110317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy.
    Choi BK; Kim YH; Kang WJ; Lee SK; Kim KH; Shin SM; Yokoyama WM; Kim TY; Kwon BS
    Cancer Res; 2007 Sep; 67(18):8891-9. PubMed ID: 17875731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment.
    Bonnefoy F; Couturier M; Clauzon A; Rémy-Martin JP; Gaugler B; Tiberghien P; Chen W; Saas P; Perruche S
    J Immunol; 2011 Jun; 186(11):6157-64. PubMed ID: 21518970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.